Off-label use of mavacamten for peri-TAVI dynamic LVOT obstruction in patients with left ventricular hypertrophy secondary to aortic stenosis
Revista Española de Cardiología (English Edition) · 2026-07
DOI: 10.1016/j.rec.2026.07.004 ↗Kurz gefasst
Fallbericht in der Zeitschrift Revista Española de Cardiología (English Edition), 2026-07. Verfasst von Alejandro Lara-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain. Electronic address: azlaragarcia@gmail.com. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain. Electronic address: azlaragarcia@gmail.com.
- Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.
Zitieren
APA
Lara-García, A., Prieto-Moriche, E., Jurado-Román, A., Galeote, G., Moreno, R., & Caro-Codón, J. (2026). Off-label use of mavacamten for peri-TAVI dynamic LVOT obstruction in patients with left ventricular hypertrophy secondary to aortic stenosis. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2026.07.004
Vancouver
Lara-García A, Prieto-Moriche E, Jurado-Román A, Galeote G, Moreno R, Caro-Codón J. Off-label use of mavacamten for peri-TAVI dynamic LVOT obstruction in patients with left ventricular hypertrophy secondary to aortic stenosis. Revista Española de Cardiología (English Edition). 2026. doi:10.1016/j.rec.2026.07.004
BibTeX
@article{LaraGarca2026,
author = {Lara-García, Alejandro and Prieto-Moriche, Elsa and Jurado-Román, Alfonso and Galeote, Guillermo and Moreno, Raúl and Caro-Codón, Juan},
title = {Off-label use of mavacamten for peri-TAVI dynamic LVOT obstruction in patients with left ventricular hypertrophy secondary to aortic stenosis},
journal = {Revista Española de Cardiología (English Edition)},
year = {2026},
doi = {10.1016/j.rec.2026.07.004}
}
EUVIMED